Mutations in the metabolic enzymes isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) occur in more than 70% of low-grade glioma and approximately 12% of high-grade glioma [6]. Here, IDH1 is linked to central nervous system cancer.